Eli Lilly stock moves after-hours on fast-track weight-loss pill talk and Nvidia AI lab deal
Eli Lilly shares rose about 1.6% in after-hours trading Monday after its R&D chief said the company expects enough supply to launch its oral obesity pill orforglipron in many countries once approved. Lilly and Nvidia also announced a $1 billion joint AI research lab as the J.P. Morgan healthcare conference began.